Dual effect of interferon (IFNγ)-induced nitric oxide on tumorigenesis and intracellular bacteria.
Nitric oxide (NO) is a key messenger involved in numerous physiological functions including inflammatory and immune responses. The functions of NO and their underlying mechanisms have been elucidated by extensive studies over the past 10 years. However, the complexity of the interactions between different levels of NO and multiple aspects of tumor development/progression as well as bacterial pathogenesis has led to apparently conflicting findings. The precise role of NO in bacterial and tumor pathogenesis involves a multitude of inter- and intracellular signaling pathways in which interferon gamma signaling and L-arginine metabolism are the major pathways involved in NO synthesis and regulation. The availability of the amino acid L-Arg can be a key factor to control the expression of inducible nitric oxide synthase (NOS2) and cellular NO levels. The role played by the NOS2/NO system both in bacterial pathogenesis and in tumor development is complex due to the dual role these molecules can play promoting or inhibiting infections and cancer. This duality brings to the table a double challenge to determine the net impact of NO on cancer or bacterial behavior and to define the therapeutic role of NO-centered anticancer or antibacterial strategies. We believe that a comprehensive and dynamic understanding of the cascade of molecular and cellular events underlying tumor biology and bacterial pathogenesis that are affected by NO will allow researchers to exploit the potential antitumor and antibacterial properties of drugs interfering with NO metabolism. The contrasting roles of NO/NOS2 in these processes are clarified in this chapter.